Synthetic Biology: Twist Bioscience Revenue Growing From $2 To $200 Million As It Eyes The $186 Billion Antibody Market The biggest reason why Twist is currently valued at $1.9 billion is the potential to use their silicon DNA synthesis platform for the discovery of new drugs.